| Year |
Citation |
Score |
| 2020 |
Panjwani MK, Atherton MJ, MaloneyHuss MA, Haran KP, Xiong A, Gupta M, Kulikovsaya I, Lacey SF, Mason NJ. Establishing a model system for evaluating CAR T cell therapy using dogs with spontaneous diffuse large B cell lymphoma. Oncoimmunology. 9: 1676615. PMID 32002286 DOI: 10.1080/2162402X.2019.1676615 |
0.405 |
|
| 2019 |
Migliorini D, Mason NJ, Posey AD. Keeping the Engine Running: The Relevance and Predictive Value of Preclinical Models for CAR-T Cell Development. Ilar Journal. PMID 31095687 DOI: 10.1093/Ilar/Ilz009 |
0.34 |
|
| 2018 |
Yin Y, Boesteanu AC, Binder ZA, Xu C, Reid RA, Rodriguez JL, Cook DR, Thokala R, Blouch K, McGettigan-Croce B, Zhang L, Konradt C, Cogdill AP, Panjwani MK, Jiang S, ... ... Mason NJ, et al. Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas. Molecular Therapy Oncolytics. 11: 20-38. PMID 30306125 DOI: 10.1016/J.Omto.2018.08.002 |
0.706 |
|
| 2016 |
Panjwani MK, Smith JB, Schutsky K, Gnanandarajah J, O'Connor CM, Powell DJ, Mason NJ. Feasibility and safety of RNA-transfected CD20-specific Chimeric Antigen Receptor T cells in dogs with spontaneous B cell lymphoma. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 27401141 DOI: 10.1038/Mt.2016.146 |
0.358 |
|
| 2006 |
Tato CM, Mason N, Artis D, Shapira S, Caamano JC, Bream JH, Liou HC, Hunter CA. Opposing roles of NF-κB family members in the regulation of NK cell proliferation and production of IFN-γ International Immunology. 18: 505-513. PMID 16481345 DOI: 10.1093/Intimm/Dxh391 |
0.717 |
|
| 2005 |
Aronson LR, Drobatz KJ, Hunter CA, Mason N. Effects of CD28 blockade on subsets of naïve T cells in cats. American Journal of Veterinary Research. 66: 483-92. PMID 15822594 DOI: 10.2460/Ajvr.2005.66.483 |
0.6 |
|
| 2004 |
Mason NJ, Fiore J, Kobayashi T, Masek KS, Choi Y, Hunter CA. TRAF6-dependent mitogen-activated protein kinase activation differentially regulates the production of interleukin-12 by macrophages in response to Toxoplasma gondii. Infection and Immunity. 72: 5662-7. PMID 15385464 DOI: 10.1128/Iai.72.10.5662-5667.2004 |
0.499 |
|
| 2004 |
Mason NJ, Artis D, Hunter CA. New lessons from old pathogens: What parasitic infections have taught us about the role of nuclear factor-κB in the regulation of immunity Immunological Reviews. 201: 48-56. PMID 15361232 DOI: 10.1111/J.0105-2896.2004.00189.X |
0.568 |
|
| 2004 |
Mason NJ, Liou HC, Hunter CA. T Cell-Intrinsic Expression of c-Rel Regulates Th1 Cell Responses Essential for Resistance to Toxoplasma gondii Journal of Immunology. 172: 3704-3711. PMID 15004174 DOI: 10.4049/Jimmunol.172.6.3704 |
0.646 |
|
| 2003 |
Hunter CA, Lieberman LA, Mason N, Pepper M, Sague SL, Tato C, Zediak V. Costimulation in resistance to infection and development of immune pathology: lessons from toxoplasma. Immunologic Research. 27: 331-40. PMID 12857979 DOI: 10.1385/Ir:27:2-3:331 |
0.696 |
|
| 2002 |
Artis D, Shapira S, Mason N, Speirs KM, Goldschmidt M, Caamaño J, Liou HC, Hunter CA, Scott P. Differential requirement for NF-kappa B family members in control of helminth infection and intestinal inflammation. Journal of Immunology (Baltimore, Md. : 1950). 169: 4481-7. PMID 12370384 DOI: 10.4049/Jimmunol.169.8.4481 |
0.744 |
|
| 2002 |
Hilliard BA, Mason N, Xu L, Sun J, Lamhamedi-Cherradi SE, Liou HC, Hunter C, Chen YH. Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. The Journal of Clinical Investigation. 110: 843-50. PMID 12235116 DOI: 10.1172/Jci15254 |
0.58 |
|
| 2002 |
Villegas EN, Lieberman LA, Mason N, Blass SL, Zediak VP, Peach R, Horan T, Yoshinaga S, Hunter CA. A role for inducible costimulator protein in the CD28- independent mechanism of resistance to Toxoplasma gondii. Journal of Immunology (Baltimore, Md. : 1950). 169: 937-43. PMID 12097399 DOI: 10.4049/Jimmunol.169.2.937 |
0.5 |
|
| 2002 |
Mason N, Aliberti J, Caamano JC, Liou HC, Hunter CA. Cutting edge: identification of c-Rel-dependent and -independent pathways of IL-12 production during infectious and inflammatory stimuli. Journal of Immunology (Baltimore, Md. : 1950). 168: 2590-4. PMID 11884420 DOI: 10.4049/Jimmunol.168.6.2590 |
0.509 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2021 |
Mason NJ, Chester N, Xiong A, Rotolo A, Wu Y, Yoshimoto S, Glassman P, Gulendran G, Siegel DL. Development of a fully canine anti-canine CTLA4 monoclonal antibody for comparative translational research in dogs with spontaneous tumors. Mabs. 13: 2004638. PMID 34856888 DOI: 10.1080/19420862.2021.2004638 |
0.291 |
|
| 2022 |
Atherton MJ, Rotolo A, Haran KP, Mason NJ. Case Report: Clinical and Serological Hallmarks of Cytokine Release Syndrome in a Canine B Cell Lymphoma Patient Treated With Autologous CAR-T Cells. Frontiers in Veterinary Science. 9: 824982. PMID 35898541 DOI: 10.3389/fvets.2022.824982 |
0.284 |
|
| 2020 |
Haran KP, Lockhart A, Xiong A, Radaelli E, Savickas PJ, Posey A, Mason NJ. Generation and Validation of an Antibody to Canine CD19 for Diagnostic and Future Therapeutic Purposes. Veterinary Pathology. 300985819900352. PMID 32081102 DOI: 10.1177/0300985819900352 |
0.265 |
|
| 2015 |
Ito D, Childress M, Mason N, Winter A, O'Brien T, Henson M, Borgatti A, Lewellen M, Krick E, Stewart J, Lahrman S, Leary J, Seelig D, Koopmeiners J, Ruetz S, et al. A double blinded, placebo-controlled pilot study to examine reduction of CD34 (+)/CD117 (+)/CD133 (+) lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma. F1000research. 4: 42. PMID 28357033 DOI: 10.12688/f1000research.6055.3 |
0.249 |
|
| 2020 |
Atherton MJ, Lenz JA, Mason NJ. Sarcomas-A barren immunological wasteland or field of opportunity for immunotherapy? Veterinary and Comparative Oncology. 18: 447-470. PMID 32246517 DOI: 10.1111/vco.12595 |
0.243 |
|
| 2021 |
Rotolo A, Atherton MJ, Kasper BT, Haran KP, Mason NJ. Genetic re-direction of canine primary T cells for clinical trial use in pet dogs with spontaneous cancer. Star Protocols. 2: 100905. PMID 34746864 DOI: 10.1016/j.xpro.2021.100905 |
0.229 |
|
| 2015 |
Gaurnier-Hausser A, Mason NJ. Assessment of canonical NF-κB activity in canine diffuse large B-cell lymphoma. Methods in Molecular Biology (Clifton, N.J.). 1280: 469-504. PMID 25736768 DOI: 10.1007/978-1-4939-2422-6_29 |
0.227 |
|
| 2023 |
Rotolo A, Whelan EC, Atherton MJ, Kulikovskaya I, Jarocha D, Fraietta JA, Kim MM, Diffenderfer ES, Cengel KA, Piviani M, Radaelli E, Duran-Struuck R, Mason NJ. Unedited allogeneic iNKT cells show extended persistence in MHC-mismatched canine recipients. Cell Reports. Medicine. 4: 101241. PMID 37852175 DOI: 10.1016/j.xcrm.2023.101241 |
0.223 |
|
| 2011 |
Sorenmo KU, Krick E, Coughlin CM, Overley B, Gregor TP, Vonderheide RH, Mason NJ. CD40-activated B cell cancer vaccine improves second clinical remission and survival in privately owned dogs with non-Hodgkin's lymphoma. Plos One. 6: e24167. PMID 21904611 DOI: 10.1371/Journal.Pone.0024167 |
0.216 |
|
| 2012 |
Ito D, Frantz AM, Williams C, Thomas R, Burnett RC, Avery AC, Breen M, Mason NJ, O'Brien TD, Modiano JF. CD40 ligand is necessary and sufficient to support primary diffuse large B-cell lymphoma cells in culture: a tool for in vitro preclinical studies with primary B-cell malignancies. Leukemia & Lymphoma. 53: 1390-8. PMID 22229753 DOI: 10.3109/10428194.2011.654337 |
0.206 |
|
| 2011 |
Gaurnier-Hausser A, Patel R, Baldwin AS, May MJ, Mason NJ. NEMO-binding domain peptide inhibits constitutive NF-κB activity and reduces tumor burden in a canine model of relapsed, refractory diffuse large B-cell lymphoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 4661-71. PMID 21610150 DOI: 10.1158/1078-0432.Ccr-10-3310 |
0.201 |
|
| 2016 |
Mason N, Gnanandarajah J, Engiles J, Gray F, Laughlin D, Gaurnier-Hausser A, Wallecha A, Huebner M, Paterson Y. Immunotherapy with a HER2 targeted Listeria induces HER2-specific immunity and demonstrates potential therapeutic effects in a phase I trial in canine osteosarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26994144 DOI: 10.1158/1078-0432.Ccr-16-0088 |
0.186 |
|
| 2012 |
Huang SH, Kozak PJ, Kim J, Habineza-Ndikuyeze G, Meade C, Gaurnier-Hausser A, Patel R, Robertson E, Mason NJ. Evidence of an oncogenic gammaherpesvirus in domestic dogs. Virology. 427: 107-17. PMID 22405628 DOI: 10.1016/J.Virol.2012.02.013 |
0.173 |
|
| 2020 |
Mason NJ. Comparative Immunology and Immunotherapy of Canine Osteosarcoma. Advances in Experimental Medicine and Biology. 1258: 199-221. PMID 32767244 DOI: 10.1007/978-3-030-43085-6_14 |
0.172 |
|
| 2014 |
Habineza Ndikuyeze G, Gaurnier-Hausser A, Patel R, Baldwin AS, May MJ, Flood P, Krick E, Propert KJ, Mason NJ. A phase I clinical trial of systemically delivered NEMO binding domain peptide in dogs with spontaneous activated B-cell like diffuse large B-cell lymphoma. Plos One. 9: e95404. PMID 24798348 DOI: 10.1371/Journal.Pone.0095404 |
0.151 |
|
| 2022 |
Atherton MJ, Mason NJ. A bitesize introduction to canine hematologic malignancies. Blood Advances. PMID 35316831 DOI: 10.1182/bloodadvances.2021005045 |
0.14 |
|
| 2023 |
Yoshimoto S, Chester N, Xiong A, Radaelli E, Wang H, Brillantes M, Gulendran G, Glassman P, Siegel DL, Mason NJ. Development and pharmacokinetic assessment of a fully canine anti-PD-1 monoclonal antibody for comparative translational research in dogs with spontaneous tumors. Mabs. 15: 2287250. PMID 38047502 DOI: 10.1080/19420862.2023.2287250 |
0.125 |
|
| 2024 |
Mason NJ. Immunotherapy with genetically engineered T cells holds promise for the treatment of nonmalignant diseases in the dog. Journal of the American Veterinary Medical Association. 1-10. PMID 38621412 DOI: 10.2460/javma.24.02.0113 |
0.12 |
|
| 2016 |
Stroud C, Dmitriev I, Kashentseva E, Bryan JN, Curiel DT, Rindt H, Reinero C, Henry CJ, Bergman PJ, Mason NJ, Gnanandarajah JS, Engiles JB, Gray F, Laughlin D, Gaurnier-Hausser A, et al. A One Health overview, facilitating advances in comparative medicine and translational research. Clinical and Translational Medicine. 5: 26. PMID 27558513 DOI: 10.1186/S40169-016-0107-4 |
0.116 |
|
| 2011 |
Braganza A, Wallace K, Pell L, Parrish CR, Siegel DL, Mason NJ. Generation and validation of canine single chain variable fragment phage display libraries. Veterinary Immunology and Immunopathology. 139: 27-40. PMID 20817275 DOI: 10.1016/J.Vetimm.2010.07.026 |
0.093 |
|
| 2003 |
Mason N, Duval D, Shofer FS, Giger U. Cyclophosphamide exerts no beneficial effect over prednisone alone in the initial treatment of acute immune-mediated hemolytic anemia in dogs: a randomized controlled clinical trial. Journal of Veterinary Internal Medicine. 17: 206-12. PMID 12683622 DOI: 10.1111/j.1939-1676.2003.tb02435.x |
0.089 |
|
| 2003 |
Zhao L, Mason NA, Strange JW, Walker H, Wilkins MR. Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic peptide activity Circulation. 107: 234-237. PMID 12538421 DOI: 10.1161/01.CIR.0000050653.10758.6B |
0.075 |
|
| 2020 |
Wang G, Wu M, Durham AC, Radaelli E, Mason NJ, Xu X, Roth DB. Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma. Plos One. 15: e0229728. PMID 32210430 DOI: 10.1371/Journal.Pone.0229728 |
0.066 |
|
| 2022 |
Fuller AM, DeVine A, Murazzi I, Mason NJ, Weber K, Eisinger-Mathason TSK. Comparative oncology reveals DNMT3B as a molecular vulnerability in undifferentiated pleomorphic sarcoma. Cellular Oncology (Dordrecht). PMID 36181640 DOI: 10.1007/s13402-022-00717-1 |
0.065 |
|
| 2007 |
Whatley SD, Mason NG, Holme SA, Anstey AV, Elder GH, Badminton MN. Gene dosage analysis identifies large deletions of the FECH gene in 10% of families with erythropoietic protoporphyria Journal of Investigative Dermatology. 127: 2790-2794. PMID 17597821 DOI: 10.1038/sj.jid.5700924 |
0.061 |
|
| 2011 |
Ahern BJ, Schaer TP, Terkhorn SP, Jackson KV, Mason NJ, Hankenson KD. Evaluation of equine peripheral blood apheresis product, bone marrow, and adipose tissue as sources of mesenchymal stem cells and their differentation potential. American Journal of Veterinary Research. 72: 127-33. PMID 21194345 DOI: 10.2460/Ajvr.72.1.127 |
0.06 |
|
| 2013 |
Whatley SD, Mason NG, Rhodes JM, Stewart MF, Reed P, Crowley V, Darby CM, Badminton MN. Pseudoexon activation in the HMBS gene as a cause of the nonerythroid form of acute intermittent porphyria. Clinical Chemistry. 59: 1123-5. PMID 23609978 DOI: 10.1373/clinchem.2012.199117 |
0.053 |
|
| 2011 |
Nie X, Pelletier Y, Mason N, Dilworth A, Giguère MA. Aphids preserved in propylene glycol can be used for reverse transcription-polymerase chain reaction detection of Potato virus Y. Journal of Virological Methods. 175: 224-7. PMID 21621556 DOI: 10.1016/j.jviromet.2011.05.019 |
0.049 |
|
| 2021 |
Wang G, Wu M, Durham AC, Mason NJ, Roth DB. Canine Oncopanel: a capture-based, NGS platform for evaluating the mutational landscape and detecting putative driver mutations in canine cancers. Veterinary and Comparative Oncology. PMID 34286913 DOI: 10.1111/vco.12746 |
0.047 |
|
| 2021 |
Ak LB, Atherton M, Bentley RT, Boudreau CE, Burton JH, Curran KM, Dow S, Giuffrida MA, Kellihan HB, Mason NJ, Oblak ML, Selmic LE, Selting KA, Singh A, Tjostheim S, et al. Veterinary Cooperative Oncology Group - Common Terminology Criteria for Adverse Events (VCOG-CTCAE v2) Following Investigational Therapy in Dogs and Cats. Veterinary and Comparative Oncology. PMID 33427378 DOI: 10.1111/vco.12677 |
0.046 |
|
| 2023 |
Mukherjee S, Shupo F, Wayi-Wayi G, Zibelnik N, Jones E, Mason N, Franklin M, Brazier J. Symptom burden in patients with idiopathic multicentric Castleman disease and its impact on daily life: an international patient and caregiver survey. Eclinicalmedicine. 64: 102192. PMID 37727459 DOI: 10.1016/j.eclinm.2023.102192 |
0.04 |
|
| 2013 |
Callan MB, Werner P, Mason NJ, Meny GM, Raducha MG, Henthorn PS. Polymorphisms in canine platelet glycoproteins identify potential platelet antigens. Comparative Medicine. 63: 348-54. PMID 24209971 |
0.038 |
|
| 2008 |
Callan MB, Appleman EH, Shofer FS, Mason NJ, Brainard BM, Groman RP. Clinical and clinicopathologic effects of plateletpheresis on healthy donor dogs Transfusion. 48: 2214-2221. PMID 18564392 DOI: 10.1111/j.1537-2995.2008.01803.x |
0.031 |
|
| 2018 |
Jackson M, Serada N, Sheehan M, Srinivasan S, Mason N, Guha M, Avadhani N. Mitochondrial genome and functional defects in osteosarcoma are associated with their aggressive phenotype. Plos One. 13: e0209489. PMID 30576337 DOI: 10.1371/journal.pone.0209489 |
0.03 |
|
| 2021 |
Gill L, Burrell S, Chamberlayne J, Lombardelli S, Mora J, Mason N, Schurer M, Merkel M, Meninger S, Ko JJ. Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods study. Orphanet Journal of Rare Diseases. 16: 187. PMID 33902669 DOI: 10.1186/s13023-021-01816-2 |
0.029 |
|
| 2016 |
LeBlanc AK, Breen M, Choyke P, Dewhirst M, Fan TM, Gustafson DL, Helman LJ, Kastan MB, Knapp DW, Levin WJ, London C, Mason N, Mazcko C, Olson PN, Page R, et al. Perspectives from man's best friend: National Academy of Medicine's Workshop on Comparative Oncology. Science Translational Medicine. 8: 324ps5. PMID 26843188 DOI: 10.1126/Scitranslmed.Aaf0746 |
0.026 |
|
| 2017 |
Dunlop WC, Mason N, Kenworthy J, Akehurst RL. Benefits, Challenges and Potential Strategies of Open Source Health Economic Models. Pharmacoeconomics. 35: 125-128. PMID 27928759 DOI: 10.1007/s40273-016-0479-8 |
0.022 |
|
| 2009 |
Whatley SD, Mason NG, Woolf JR, Newcombe RG, Elder GH, Badminton MN. Diagnostic strategies for autosomal dominant acute porphyrias: retrospective analysis of 467 unrelated patients referred for mutational analysis of the HMBS, CPOX, or PPOX gene. Clinical Chemistry. 55: 1406-14. PMID 19460837 DOI: 10.1373/clinchem.2008.122564 |
0.022 |
|
| 2017 |
Wang G, Wu M, Maloneyhuss MA, Wojcik J, Durham AC, Mason NJ, Roth DB. Actionable mutations in canine hemangiosarcoma. Plos One. 12: e0188667. PMID 29190660 DOI: 10.1371/journal.pone.0188667 |
0.018 |
|
| 2013 |
Chaudhuri E, Mason NC, Newbery N, Goddard AF. Career choices of junior doctors: is the physician an endangered species? Clinical Medicine (London, England). 13: 330-5. PMID 23908498 DOI: 10.7861/clinmedicine.13-4-330 |
0.016 |
|
| 2021 |
Morrison MM, Mason NT, Forde BL, Stone PR, Fowler PV, Thompson JMD. Speech Outcomes of a National Cohort of Children with Orofacial Cleft at 5 and 10 Years of age. The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association. 10556656211044939. PMID 34672811 DOI: 10.1177/10556656211044939 |
0.01 |
|
| 2021 |
Edirisooriya M, Jack W, Twelves D, Royds J, Scott F, Mason N, Turnbull A, Dixon JM. Diagnostic accuracy of core biopsy in patients presenting with axillary lymphadenopathy and suspected non-breast malignancy. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. PMID 33579581 DOI: 10.1016/j.ejso.2021.01.023 |
0.01 |
|
| 2013 |
Mason NC, Chaudhuri E, Newbery N, Goddard AF. Training in general medicine - are juniors getting enough experience? Clinical Medicine (London, England). 13: 434-9. PMID 24115695 DOI: 10.7861/clinmedicine.13-5-434 |
0.01 |
|
| Hide low-probability matches. |